Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 3, 2015
Patent Application Number
13160370
Date Filed
June 14, 2011
Patent Primary Examiner
Patent abstract
The present invention comprises novel conjugates and immunogens derived from gemcitabine and unique antibodies generated by using gemcitabine linked immunogens, which conjugates immunogens and antibodies, are useful in immunoassays for the quantification and monitoring of gemcitabine in biological fluids.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
